SCHEMBL3230514

SCHEMBL3230514

COc1cc(C(=O)O)cc(C)c1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.78
▸ CA1 P00915 3/20 0.78
▸ CA2 P00918 3/20 0.78
▸ CA4 P22748 3/20 0.78
▸ CA6 P23280 3/20 0.78
▸ CA7 P43166 3/20 0.78
▸ CA9 Q16790 3/20 0.78
▸ CA14 Q9ULX7 3/20 0.78
▸ CA3 P07451 2/20 0.78
▸ CA5A P35218 2/20 0.78
▸ CA5B Q9Y2D0 2/20 0.78
▸ PKM P14618 1/20 0.78
▸ PTGS2 P35354 1/20 0.72
▸ TPMT P51580 3/20 0.58
▸ LMNA P02545 3/20 0.55
▸ HTT P42858 2/20 0.55
▸ CNR2 P34972 1/20 0.54
▸ EGFR P00533 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ ERN1 O75460 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Syringic Acid SCHEMBL27602358 0.88 CA12 (1.00) CA12CA1CA2CA4CA6
Syringic Acid SCHEMBL42751 0.88 CA12 (1.00) CA12CA1CA2CA4CA6
Syringic Acid SCHEMBL30250854 0.86 PKM (0.96) CA12CA1CA2CA4CA6
Syringic Acid SCHEMBL27832093 0.86 PKM (0.96) CA12CA1CA2CA4CA6
SCHEMBL12396894 0.85 LMNA (0.78) CA12CA1CA2CA4CA6
SCHEMBL975675 0.84 PTGS2 (1.00) CA12CA1CA2CA4CA6
SCHEMBL30615314 0.84 PTGS2 (1.00) CA12CA1CA2CA4CA6
SCHEMBL15242142 0.83 CA1 (0.53) CA12CA1CA2CA4CA6
SCHEMBL402146 0.83 KDM4E (0.55) CA12CA1CA2CA4CA6
SCHEMBL16260620 0.82 CA12 (0.62) CA12CA1CA2CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117603159-A Thiadiazole compound containing hindered phenol group, preparation method thereof and application thereof in field of lubricating oil additives 大连理工大学盘锦产业技术研究院 2024-02-27 — — CN claimed
US-20240241438-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-18 — — US disclosed
US-20240210824-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-06-27 — — US disclosed
CN-117603159-A Thiadiazole compound containing hindered phenol group, preparation method thereof and application thereof in field of lubricating oil additives 大连理工大学盘锦产业技术研究院 2024-02-27 — — CN disclosed
US-11814597-B2 Process for the production of oxidized wood products ORGANOFUEL SWEDEN AB (SE) 2023-11-14 — — US disclosed
US-9903028-B2 Nitroxyl-mediated oxidation of lignin and polycarboxylated products WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2018-02-27 — — US disclosed
US-20180020708-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS PEPSICO, INC. 2018-01-25 — — US disclosed
US-20170342219-A1 POLYCARBOXYLATED COMPOUNDS AND COMPOSITIONS CONTAINING SAME WISCONSIN ALUMNI RESEARCH FOUNDATION 2017-11-30 — — US disclosed
US-20170342574-A1 NITROXYL-MEDIATED OXIDATION OF LIGNIN AND POLYCARBOXYLATED PRODUCTS WISCONSIN ALUMNI RESEARCH FOUNDATION 2017-11-30 — — US disclosed
US-20170080040-A1 DECOCTION OF OLIVE LEAVES EVERGREEN LIFE PRODUCTS S.R.L. (IT) 2017-03-23 — — US disclosed
US-20110287059-A1 HONEY ANALYSIS COMVITA NEW ZEALAND LIMITED (NZ) 2011-11-24 — — US disclosed
US-20110212913-A1 THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION PROVEXIS NATURAL PRODUCTS LIMITED (GB) 2011-09-01 — — US disclosed
US-20110206794-A1 FRUIT EXTRACTS PROVEXIS NATURAL PRODUCTS LIMITED (GB) 2011-08-25 — — US disclosed
US-7858665-B2 Drugs for chronic pain NICOX S.A. (FR) 2010-12-28 — — US disclosed
US-20100069499-A1 AMIDE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-18 — — US disclosed
EP-2151431-A1 AMIDE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2010-02-10 — — EP disclosed
US-7642289-B2 Drugs for chronic pain NICOX S.A. (FR) 2010-01-05 — — US disclosed
US-20090239832-A1 DRUGS FOR CHRONIC PAIN NICOX SA (FR) 2009-09-24 — — US disclosed
WO-2009064838-A1 AQUEOUS FORMULATION OF ERYTHROPOIESIS STIMULATING PROTEIN STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION AMGEN, INC. (US) 2009-05-22 — — WO disclosed
US-20090035248-A1 Fast Degrading Polymers RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2009-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239832-A1 DRUGS FOR CHRONIC PAIN OPRK1, OPRL1, OPRD1 CA12 3316/4885CA1 1813/4885CA2 860/4885
US-11814597-B2 Process for the production of oxidized wood products NOX4, NOX5, AOC2 CA12 854/4885CA1 833/4885CA2 398/4885
US-20110206794-A1 FRUIT EXTRACTS F3, NEU3, GP6 CA12 2917/4885CA1 4474/4885CA2 2560/4885
US-20240210824-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SCO2, CBR1, OXGR1 CA12 224/4885CA1 113/4885CA2 87/4885
US-20090035248-A1 Fast Degrading Polymers MMP1, MMP14, MMP13 CA12 1515/4885CA1 3893/4885CA2 1635/4885
US-20100069499-A1 AMIDE COMPOUND AND USE THEREOF CBR1, CBR3, GBA1 CA12 70/4885CA1 333/4885CA2 841/4885
US-20110287059-A1 HONEY ANALYSIS GLO1, GLMN, AGER CA12 811/4885CA1 1225/4885CA2 1931/4885
US-20110212913-A1 THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION F3, F2, F12 CA12 3189/4885CA1 4376/4885CA2 1010/4885
US-20180020708-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS GPR119, TAS2R42, TAS2R31 CA12 1005/4885CA1 1053/4885CA2 1101/4885
US-20170080040-A1 DECOCTION OF OLIVE LEAVES ELOVL5, ALOX5, LIPA CA12 3540/4885CA1 3164/4885CA2 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback